|
|
Volumn 25, Issue 15, 2004, Pages 1364-1365
|
|
Long-term clopidogrel therapy in the drug-eluting stent era: Beyond CREDO and PCI-CURE [2] (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
RAPAMYCIN;
BLEEDING TENDENCY;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DIABETES MELLITUS;
DRUG ELUTING STENT;
HEART INFARCTION;
HEART INJURY;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
LETTER;
LONG TERM CARE;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
THROMBOSIS;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY DISEASE;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
STENTS;
TICLOPIDINE;
|
|
EID: 3242880723
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ehj.2004.05.025 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|
